FDA NDC Directory · JSON-LD · Markdown

Flucytosine

NDC 42385-983 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerLaurus Labs Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA218005
Dosage form / routeCAPSULE · ORAL
Active ingredientsFLUCYTOSINE (250 mg/1)
Marketing started20250724
Package count2

External sources

Source: openFDA. Public-domain (CC0).